Original Research
Published on 17 Oct 2024
Precuneal hyperperfusion in patients with attention-deficit/hyperactivity disorder-comorbid nociplastic pain
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1480546
- 999 views
Type at least 3 characters
2,249 articles
Articles
Review
Published on 17 Oct 2024
The role of exercise-related FNDC5/irisin in depression
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1461995
- 539 views
Systematic Review
Published on 17 Oct 2024
The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1411631
- 973 views
Original Research
Published on 16 Oct 2024
Decreasing brain activity caused by acute administration of ketamine and alcohol – A randomized, controlled, observer-blinded experimental study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1456009
- 367 views
Editorial
Published on 14 Oct 2024
Editorial: New players on the monoaminergic field: relevance to the mental disorders
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1504261
- 376 views
Original Research
Published on 14 Oct 2024
Identification and experimental validation of hub genes underlying depressive-like behaviors induced by chronic social defeat stress
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1472468
- 444 views
Brief Research Report
Published on 10 Oct 2024
Chronic exposure to inhaled vaporized cannabis high in Δ9-THC suppresses Adderall-induced brain activity
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413812
- 592 views
Original Research
Published on 09 Oct 2024
Fentanyl enhances immune cell response through TLR4/MD-2 complex
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1468644
- 523 views
Original Research
Published on 07 Oct 2024
Inhibition of HCN1 currents by norquetiapine, an active metabolite of the atypical anti-psychotic drug quetiapine
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1445509
- 554 views
Editorial
Published on 03 Oct 2024
Editorial: Reviews in neuropharmacology 2023: microbiota gut-brain axis, therapeutic insights for neurodegenerative diseases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1499072
- 435 views
Mini Review
Published on 02 Oct 2024
Autophagy is a promising process for linking inflammation and redox homeostasis in Down syndrome
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491563
- 448 views
Brief Research Report
Published on 02 Oct 2024
Isoflurane-lipid emulsion injection as an anticonvulsant and neuroprotectant treatment for nerve agent exposure
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1466351
- 461 views
Review
Published on 02 Oct 2024
Single-cell profiling of cellular changes in the somatic peripheral nerves following nerve injury
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1448253
- 446 views
Original Research
Published on 02 Oct 2024
Exploring novel natural compound-based therapies for Duchenne muscular dystrophy management: insights from network pharmacology, QSAR modeling, molecular dynamics, and free energy calculations
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1395014
- 696 views
Brief Research Report
Published on 02 Oct 2024
Synergistic effects of peripheral GABA and GABA-transaminase inhibitory drugs on food intake control and weight loss in high-fat diet-induced obese mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1487585
- 942 views
Original Research
Published on 01 Oct 2024
Hemoglobin α-derived peptides VD-hemopressin (α) and RVD-hemopressin (α) are involved in electroacupuncture inhibition of chronic pain
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1439448
- 509 views